OPKO Health Price to Book Ratio 2010-2024 | OPK
Historical price to book ratio values for OPKO Health (OPK) over the last 10 years. The current price to book ratio for OPKO Health as of November 07, 2024 is 0.73.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| OPKO Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-06 | 1.47 | 0.73 | |
| 2024-06-30 | 1.25 | $2.00 | 0.62 |
| 2024-03-31 | 1.20 | $1.80 | 0.67 |
| 2023-12-31 | 1.51 | $1.80 | 0.84 |
| 2023-09-30 | 1.60 | $1.87 | 0.86 |
| 2023-06-30 | 2.17 | $1.99 | 1.09 |
| 2023-03-31 | 1.46 | $2.01 | 0.73 |
| 2022-12-31 | 1.25 | $2.02 | 0.62 |
| 2022-09-30 | 1.89 | $2.11 | 0.90 |
| 2022-06-30 | 2.53 | $2.23 | 1.14 |
| 2022-03-31 | 3.44 | $2.37 | 1.45 |
| 2021-12-31 | 4.81 | $2.47 | 1.95 |
| 2021-09-30 | 3.65 | $2.59 | 1.41 |
| 2021-06-30 | 4.05 | $2.56 | 1.58 |
| 2021-03-31 | 4.29 | $2.53 | 1.69 |
| 2020-12-31 | 3.95 | $2.49 | 1.58 |
| 2020-09-30 | 3.69 | $2.42 | 1.52 |
| 2020-06-30 | 3.41 | $2.37 | 1.44 |
| 2020-03-31 | 1.34 | $2.31 | 0.58 |
| 2019-12-31 | 1.47 | $2.41 | 0.61 |
| 2019-09-30 | 2.09 | $2.67 | 0.78 |
| 2019-06-30 | 2.44 | $2.78 | 0.88 |
| 2018-12-31 | 3.01 | $3.06 | 0.99 |
| 2018-09-30 | 3.46 | $3.20 | 1.08 |
| 2018-06-30 | 4.70 | $3.24 | 1.45 |
| 2018-03-31 | 3.17 | $3.26 | 0.97 |
| 2017-12-31 | 4.90 | $3.30 | 1.49 |
| 2019-03-31 | 2.61 | $2.86 | 0.91 |
| 2017-09-30 | 6.86 | $3.73 | 1.84 |
| 2017-06-30 | 6.58 | $3.77 | 1.75 |
| 2017-03-31 | 8.00 | $3.77 | 2.12 |
| 2016-12-31 | 9.30 | $3.75 | 2.48 |
| 2016-09-30 | 10.59 | $3.78 | 2.80 |
| 2016-06-30 | 9.34 | $3.68 | 2.54 |
| 2016-03-31 | 10.39 | $3.65 | 2.85 |
| 2015-12-31 | 10.05 | $3.63 | 2.77 |
| 2015-09-30 | 8.41 | $3.61 | 2.33 |
| 2015-06-30 | 16.08 | $1.78 | 9.01 |
| 2015-03-31 | 14.17 | $1.77 | 7.99 |
| 2014-12-31 | 9.99 | $1.93 | 5.17 |
| 2014-09-30 | 8.51 | $2.06 | 4.14 |
| 2014-06-30 | 8.84 | $2.14 | 4.12 |
| 2014-03-31 | 9.32 | $2.01 | 4.63 |
| 2013-12-31 | 8.44 | $2.12 | 3.99 |
| 2013-09-30 | 8.81 | $2.13 | 4.13 |
| 2013-06-30 | 7.10 | $0.93 | 7.65 |
| 2013-03-31 | 7.63 | $0.95 | 8.03 |
| 2012-12-31 | 4.81 | $0.59 | 8.15 |
| 2012-09-30 | 4.18 | $0.49 | 8.45 |
| 2012-06-30 | 4.60 | $0.51 | 8.97 |
| 2011-12-31 | 4.90 | $0.54 | 9.06 |
| 2011-09-30 | 4.33 | $0.36 | 12.07 |
| 2011-06-30 | 3.69 | $0.39 | 9.56 |
| 2011-03-31 | 3.73 | $0.43 | 8.60 |
| 2010-12-31 | 3.67 | $0.09 | 40.64 |
| 2012-03-31 | 4.73 | $0.53 | 9.01 |
| 2010-09-30 | 2.24 | $0.08 | 28.39 |
| 2010-06-30 | 2.26 | $0.20 | 11.52 |
| 2010-03-31 | 1.98 | $0.22 | 9.05 |
| 2009-12-31 | 1.83 | $0.12 | 14.70 |
| 2009-09-30 | 2.28 | $0.25 | 8.99 |
| 2009-03-31 | 0.98 | $-0.04 | -25.26 |
| 2009-06-30 | 1.77 | $0.15 | 11.49 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.025B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.078B | 26.12 |
| Intuitive Surgical (ISRG) | United States | $183.628B | 96.01 |
| Alcon (ALC) | Switzerland | $45.117B | 31.76 |
| IQVIA Holdings (IQV) | United States | $40.157B | 22.12 |
| Edwards Lifesciences (EW) | United States | $39.608B | 24.62 |
| IDEXX Laboratories (IDXX) | United States | $34.672B | 40.83 |
| DexCom (DXCM) | United States | $26.799B | 40.36 |
| Waters (WAT) | United States | $22.960B | 33.95 |
| STERIS (STE) | Ireland | $22.437B | 25.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.922B | 0.00 |
| Hologic (HOLX) | United States | $18.696B | 19.73 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 12.70 |
| Sysmex ADR (SSMXY) | Japan | $11.851B | 37.16 |
| Globus Medical (GMED) | United States | $11.200B | 28.52 |
| Teleflex (TFX) | United States | $9.378B | 14.96 |
| Penumbra (PEN) | United States | $8.969B | 87.86 |
| Masimo (MASI) | United States | $8.917B | 43.43 |
| Glaukos (GKOS) | United States | $7.755B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.126B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.542B | 25.75 |
| Inari Medical (NARI) | United States | $3.119B | 0.00 |
| TransMedics (TMDX) | United States | $2.898B | 91.86 |
| LivaNova (LIVN) | United Kingdom | $2.829B | 16.33 |
| Veracyte (VCYT) | United States | $2.811B | 85.09 |
| Nihon Kohden (NHNKY) | Japan | $2.519B | 15.68 |
| Tandem Diabetes Care (TNDM) | United States | $2.242B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.227B | 18.14 |
| Integra LifeSciences Holdings (IART) | United States | $2.060B | 10.77 |
| RxSight (RXST) | United States | $2.024B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.257B | 0.00 |
| Artivion (AORT) | United States | $1.233B | 113.23 |
| Pulse Biosciences (PLSE) | United States | $1.110B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.963B | 16.37 |
| OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.726B | 18.33 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| IRadimed (IRMD) | United States | $0.712B | 38.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| AxoGen (AXGN) | United States | $0.672B | 0.00 |
| SiBone (SIBN) | United States | $0.669B | 0.00 |
| Paragon 28 (FNA) | United States | $0.605B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.485B | 0.00 |
| CVRx (CVRX) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.99 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 19.57 |
| Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
| NeuroPace (NPCE) | United States | $0.228B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| 908 Devices (MASS) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 16.32 |
| EDAP TMS S.A (EDAP) | France | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |